- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/015 - Hemosporidia antigens, e.g. Plasmodium antigens
Patent holdings for IPC class A61K 39/015
Total number of patents in this class: 640
10-year publication summary
|
44
|
50
|
51
|
34
|
46
|
41
|
28
|
27
|
43
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1700 |
25 |
| Oxford University Innovation Limited | 1497 |
20 |
| Institut Pasteur | 789 |
19 |
| Sanaria Inc. | 35 |
19 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2842 |
18 |
| Artificial Cell Technologies, Inc. | 38 |
15 |
| The United States of America as represented by the Secretary of the Navy | 2726 |
10 |
| Isis Innovation Limited | 513 |
10 |
| Leidos, Inc. | 202 |
10 |
| The Trustees of the University of Pennsylvania | 4262 |
9 |
| Seattle Children's Hospital, d/b/a Seattle Children's Research Institute | 115 |
9 |
| BioNTech SE | 579 |
9 |
| The United States of America as represented by the Secretary of the Army | 1185 |
8 |
| GenVec, Inc. | 59 |
8 |
| Griffith University | 154 |
8 |
| Rhode Island Hospital | 192 |
8 |
| University of Washington | 2257 |
8 |
| Board of Trustees of the University of Arkansas | 787 |
7 |
| Modernatx, Inc. | 1201 |
7 |
| The Texas a & M University System | 1602 |
7 |
| Other owners | 406 |